Entyvio and Chlorthalidone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Entyvio (vedolizumab) and Chlorthalidone (chlorthalidone). Common drug interactions include breast cancer among females and influenza among males.

The phase IV clinical study analyzes what interactions people have when they take Entyvio and Chlorthalidone. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Entyvio?

Entyvio has active ingredients of vedolizumab. It is often used in crohn's disease. eHealthMe is studying from 23,827 Entyvio users. Check the latest studies of Entyvio.

What is Chlorthalidone?

Chlorthalidone has active ingredients of chlorthalidone. It is often used in high blood pressure. eHealthMe is studying from 12,482 Chlorthalidone users. Check the latest studies of Chlorthalidone.

On Aug, 12, 2026

17 people who take Entyvio and Chlorthalidone together, and have interactions are studied.

Entyvio and Chlorthalidone drug interactions.

What are the common drug interactions of Entyvio and Chlorthalidone, by gender? *:

female:

Breast cancer
Diarrhoea
Discomfort
Hidradenitis (chronic disease of a type of sweat gland)
Polyarthritis (arthritis which involves 5 or more joints simultaneously)
Blood immunoglobulin g decreased
Blood immunoglobulin m decreased
Cd4 lymphocytes decreased
Leukopenia (less number of white blood cells in blood)
Lymphopenia (an abnormally low level of lymphocytes in the blood)

male:

Influenza
Influenza like illness
Drug level below therapeutic
Hypersensitivity
Hypotension (abnormally low blood pressure)
Tongue disorder (disease of tongue)
Tooth infection
Waist circumference increased
Nausea (feeling of having an urge to vomit)
Pneumonia

What are the common drug interactions of Entyvio and Chlorthalidone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Breast cancer
Blood immunoglobulin g decreased
Blood immunoglobulin m decreased
Cd4 lymphocytes decreased
Leukopenia (less number of white blood cells in blood)
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Polyarthritis (arthritis which involves 5 or more joints simultaneously)
Toxoplasma serology positive

60+:

Influenza
Influenza like illness
Waist circumference increased
Nausea (feeling of having an urge to vomit)
Pneumonia
White blood cell count decreased
Colitis ulcerative (inflammation of colon with ulcer)
Drug level below therapeutic
Hypotension (abnormally low blood pressure)
Tongue disorder (disease of tongue)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 17.65%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 17.65%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 11.76%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 11.76%
High Blood Cholesterol: 1 person, 5.88%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 5.88%
Cardiac Disorder: 1 person, 5.88%
Colitis (inflammation of colon): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Entyvio and Chlorthalidone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously